Dupilumab reduces COPD exacerbations and Type 2 inflammation biomarkers, with strongest benefit in patients with high ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

Maintaining good overall health is key to living a long life, but we may want to particularly focus on the state of our brain ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

Scientists have been working on the artificial production of blood for several decades. Now, researchers from the University of Konstanz and Queen Mary University of London have taken an important ...

A breakthrough in the understanding of how mammals create red blood cells could lead to opportunities for artificial blood to ...

Recommended management of asthma, including appropriate diagnostic steps and use of fractional exhaled nitric oxide (FeNO) in ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.

Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations and hospitalizations in those with elevated blood eosinophil counts.

Eosinophils are a type of white blood cell that are key players in how the body responds to allergic reactions and asthma. Some people can have too few or too many of these cells.

Human populations that left Africa evolved quickly whereas Neanderthals stayed the same, according to an analysis of blood group systems.